Results 1 to 10 of about 6,741 (226)

Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model

open access: goldPLoS Genetics, 2013
There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpinning polyglutamine (PolyQ) disorders, including Spinocerebellar Ataxia Type-3 (SCA3). Here, we augment the proteostasis network of Drosophila SCA3 models
Nancy M Bonini, James Shorter
exaly   +7 more sources

Autophagy- and oxidative stress-related protein deregulation mediated by extracellular vesicles of human MJD/SCA3 iPSC-derived neuroepithelial stem cells and differentiated neural cultures [PDF]

open access: goldCell Death and Disease
Extracellular vesicles (EVs) have been associated with the transport of molecules related to the pathological processes in neurodegenerative diseases. Machado-Joseph disease (MJD) is a neurodegenerative disorder triggered by mutant ataxin-3 protein that ...
Liliana S. Mendonça   +6 more
doaj   +5 more sources

Cerebellar lncRNA Expression Profile Analysis of SCA3/MJD Mice [PDF]

open access: goldInternational Journal of Genomics, 2018
Spinocerebellar ataxia type 3 (SCA3) or Machado-Joseph disease (MJD) is the most common autosomal dominant spinocerebellar ataxia in China with highly clinical heterogeneity, such as progressive cerebellar ataxia, dysarthria, pyramidal signs, external ...
Zhe Long   +15 more
doaj   +5 more sources

Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report [PDF]

open access: goldBMC Neurology, 2011
Background Machado-Joseph disease (MJD), or spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disorder of late onset, which is caused by a CAG repeat expansion in the coding region of the ATXN3 gene.
Vasconcelos João   +9 more
doaj   +11 more sources

MR Imaging of SCA3/MJD [PDF]

open access: goldFrontiers in Neuroscience, 2020
Spinocerebellar ataxia type 3/Machado–Joseph disease (SCA3/MJD) is a progressive autosomal dominantly inherited cerebellar ataxia characterized by the aggregation of polyglutamine-expanded protein within neuronal nuclei in the brain, which can lead to ...
Na Wan, Linlin Wan, Beisha Tang
exaly   +6 more sources

The SCA1 (Spinocerebellar ataxia type 1) and MJD (Machado-Joseph disease) CAG repeats in normal individuals: segregation analysis and allele frequencies [PDF]

open access: goldGenetics and Molecular Biology, 2003
Spinocerebellar ataxia type 1 (SCA1) and Machado-Joseph disease (MJD/SCA3) are autosomal dominant neurodegenerative diseases caused by expansions of a CAG trinucleotide repeat in the SCA1 and MJD genes.
Cláudia Emília Vieira Wiezel   +2 more
doaj   +3 more sources

Gene-Related Cerebellar Neurodegeneration in SCA3/MJD: A Case-Controlled Imaging-Genetic Study [PDF]

open access: goldFrontiers in Neurology, 2019
Background: Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is one of the nine polyglutamine (polyQ) diseases and is caused by a CAG repeat expansion within the coding sequence of the ATXN3 gene.
Huirong Peng   +19 more
doaj   +2 more sources

Understanding barriers to treatment-seeking in Mseleni joint disease: A multistaged study in rural KwaZulu-Natal, South Africa [PDF]

open access: yesAfrican Journal of Primary Health Care & Family Medicine
Background: Mseleni joint disease (MJD) is a degenerative chondrodysplasia of unknown aetiology that is endemic to uMkhanyekude in KwaZulu-Natal, South Africa.
Elizabeth S. Dinkele   +3 more
doaj   +2 more sources

Global DNA methylation is not elevated in blood samples from Machado-Joseph disease mutation carriers [PDF]

open access: yesEpigenetics
Machado-Joseph disease (MJD) is an autosomal dominant spinocerebellar ataxia (SCA) caused by a polyglutamine expansion in the ataxin-3 protein, which initiates a cascade of pathogenic events, including transcriptional dysregulation.
Luís Teves   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy